Cure Genetics Competitors and Similar CompaniesClear all

Cure Genetics's competitors and similar companies include Reglagene and Exicure.
Cure Genetics
Cure Genetics
Cure Genetics (also known as Suzhou Kerui Gene Biotechnology, 克睿基因) is a biotechnology company committed to developing applications of technologies in medicines and molecular diagnostics, which contribute to the treatment of cancers and genetic diseases.
Reglagene
Reglagene
Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment.
Exicure
Exicure
Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.
Founding Date
Founding Date
2016
Founding Date
2016
Founding Date
2011
Type
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
HQ
Locations
Tucson, US HQ
Locations
Skokie, US HQ
Chicago, US
Employees
Employees
15
Employees
14
Employees
29

Funding

Latest funding round
Latest funding round
$ 9.5m (over 6 years ago)
Latest funding round
$ 546.4k (almost 8 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 26.5m
Total funding raised
$ 546.4k
Total funding raised
$ 94m
For sources of this data, please see the company profile

View Company Profiles

Reglagene
HQ
Tucson, US
Employees
14

Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment.

View company
Exicure
HQ
Skokie, US
Employees
29

Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.

View company